| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 9.713 | 27.640 | 43.656 | 32.423 | 33.367 | 30.410 | 22.132 | 25.437 |
| Total Income - EUR | 0 | 0 | 9.713 | 27.640 | 43.972 | 32.436 | 36.235 | 30.410 | 22.132 | 25.437 |
| Total Expenses - EUR | 0 | 0 | 2.517 | 17.061 | 32.828 | 21.660 | 27.339 | 25.116 | 32.641 | 22.675 |
| Gross Profit/Loss - EUR | 0 | 0 | 7.195 | 10.579 | 11.144 | 10.776 | 8.895 | 5.295 | -10.509 | 2.762 |
| Net Profit/Loss - EUR | 0 | 0 | 6.904 | 10.302 | 10.704 | 10.462 | 8.895 | 5.238 | -10.730 | 2.507 |
| Employees | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Amolex Lira Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 5.335 | 16.261 | 7.442 | 1.007 | 802 | 696 | 589 |
| Current Assets | 0 | 45 | 7.330 | 13.397 | 12.194 | 30.912 | 39.620 | 7.513 | 2.226 | 5.085 |
| Inventories | 0 | 0 | 0 | 441 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 47 | 43 | 0 | 0 | 0 | 81 | 80 |
| Cash | 0 | 45 | 7.330 | 12.910 | 12.151 | 30.912 | 39.620 | 7.513 | 2.146 | 5.005 |
| Shareholders Funds | 0 | 45 | 6.947 | 17.122 | 27.495 | 31.903 | 40.091 | 7.201 | -3.551 | -1.023 |
| Social Capital | 0 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 0 | 382 | 1.610 | 960 | 6.450 | 536 | 1.113 | 6.473 | 6.697 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Amolex Lira Srl